Download PDF
Clin Colon Rectal Surg 2017; 30(05): 404-414
DOI: 10.1055/s-0037-1606118
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Locally Advanced Disease and Pelvic Exenterations

Christos Kontovounisios
1   Department of Colorectal Surgery, The Royal Marsden Hospital, Chelsea, London, United Kingdom
2   Department of Surgery and Cancer, Imperial College, London, United Kingdom
,
Paris Tekkis
1   Department of Colorectal Surgery, The Royal Marsden Hospital, Chelsea, London, United Kingdom
2   Department of Surgery and Cancer, Imperial College, London, United Kingdom
› Author Affiliations
Further Information

Publication History

Publication Date:
01 December 2017 (online)

    Permissions and Reprints

Abstract

Advanced primary and recurrent colorectal cancer can be successfully treated by experienced, dedicated centers delivering good outcomes with low mortality and morbidity. Development and implementation of a comprehensive referral pathway is to be encouraged. Multidisciplinary team management is essential in the management of this complex group of patients and is associated with significantly more complete preoperative evaluation and more accurate provision of patient information, as well as improved access to the most appropriate individualized management plan. A structured selection process can improve outcomes through standardized approaches to service delivery to provide the highest quality of care.

Keywords

primary advanced rectal cancer - recurrent rectal cancer - beyond total mesorectal excision - multidisciplinary management
 

  • Reference

  • 1 Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J. , et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49 (06) 1374-1403
    CrossrefPubMedGoogle Scholar
  • 2 Meyer JE, Narang T, Schnoll-Sussman FH, Pochapin MB, Christos PJ, Sherr DL. Increasing incidence of rectal cancer in patients aged younger than 40 years: an analysis of the surveillance, epidemiology, and end results database. Cancer 2010; 116 (18) 4354-4359
    CrossrefPubMedGoogle Scholar
  • 3 MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 2006; 333 (7572): 779
    CrossrefPubMedGoogle Scholar
  • 4 Solum AM, Riffenburgh RH, Johnstone PA. Survival of patients with untreated rectal cancer. J Surg Oncol 2004; 87 (04) 157-161
    CrossrefPubMedGoogle Scholar
  • 5 Carlsson U, Lasson A, Ekelund G. Recurrence rates after curative surgery for rectal carcinoma, with special reference to their accuracy. Dis Colon Rectum 1987; 30 (06) 431-434
    CrossrefPubMedGoogle Scholar
  • 6 Arnott SJ. The value of combined 5-fluorouracil and x-ray therapy in the palliation of locally recurrent and inoperable rectal carcinoma. Clin Radiol 1975; 26 (02) 177-182
    CrossrefPubMedGoogle Scholar
  • 7 MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993; 341 (8843): 457-460
    CrossrefPubMedGoogle Scholar
  • 8 van Gijn W, Marijnen CA, Nagtegaal ID. , et al; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 2011; 12 (06) 575-582
    CrossrefPubMedGoogle Scholar
  • 9 Sagar PM, Pemberton JH. Surgical management of locally recurrent rectal cancer. Br J Surg 1996; 83 (03) 293-304
    CrossrefPubMedGoogle Scholar
  • 10 Ito Y, Ohtsu A, Ishikura S. , et al. Efficacy of chemoradiotherapy on pain relief in patients with intrapelvic recurrence of rectal cancer. Jpn J Clin Oncol 2003; 33 (04) 180-185
    CrossrefPubMedGoogle Scholar
  • 11 Nielsen MB, Rasmussen PC, Lindegaard JC, Laurberg S. A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database. Colorectal Dis 2012; 14 (09) 1076-1083
    CrossrefPubMedGoogle Scholar
  • 12 Bhangu A, Ali SM, Darzi A, Brown G, Tekkis P. Meta-analysis of survival based on resection margin status following surgery for recurrent rectal cancer. Colorectal Dis 2012; 14 (12) 1457-1466
    CrossrefPubMedGoogle Scholar
  • 13 Heriot AG, Byrne CM, Lee P. , et al. Extended radical resection: the choice for locally recurrent rectal cancer. Dis Colon Rectum 2008; 51 (03) 284-291
    CrossrefPubMedGoogle Scholar
  • 14 Beyond TME Collaborative. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg 2013; 100 (08) E1-E33
    CrossrefPubMedGoogle Scholar
  • 15 Tepper JE, O'Connell M, Hollis D, Niedzwiecki D, Cooke E, Mayer RJ. ; Intergroup Study 0114. Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from Intergroup Study 0114. J Clin Oncol 2003; 21 (19) 3623-3628
    CrossrefPubMedGoogle Scholar
  • 16 Ngan SY, Fisher R, Burmeister BH. , et al. Promising results of a cooperative group phase II trial of preoperative chemoradiation for locally advanced rectal cancer (TROG 9801). Dis Colon Rectum 2005; 48 (07) 1389-1396
    CrossrefPubMedGoogle Scholar
  • 17 Krook JE, Moertel CG, Gunderson LL. , et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991; 324 (11) 709-715
    CrossrefPubMedGoogle Scholar
  • 18 Salerno G, Daniels IR, Brown G. Magnetic resonance imaging of the low rectum: defining the radiological anatomy. Colorectal Dis 2006; 8 (Suppl. 03) 10-13
    PubMedGoogle Scholar
  • 19 Siegel R, Burock S, Wernecke KD. , et al. Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society. BMC Cancer 2009; 9: 50
    CrossrefPubMedGoogle Scholar
  • 20 Pilipshen SJ, Heilweil M, Quan SH, Sternberg SS, Enker WE. Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer 1984; 53 (06) 1354-1362
    CrossrefPubMedGoogle Scholar
  • 21 Ogunbiyi OA, McKenna K, Birnbaum EH, Fleshman JW, Kodner IJ. Aggressive surgical management of recurrent rectal cancer--is it worthwhile?. Dis Colon Rectum 1997; 40 (02) 150-155
    CrossrefPubMedGoogle Scholar
  • 22 Sauer R, Liersch T, Merkel S. , et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 2012; 30 (16) 1926-1933
    CrossrefPubMedGoogle Scholar
  • 23 Van Cutsem E, Dicato M, Haustermans K. , et al. The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007. Ann Oncol 2008; 19 (Suppl. 06) vi1-vi8
    PubMedGoogle Scholar
  • 24 Denost Q, Kontovounisios C, Rasheed S. , et al. Individualizing surgical treatment based on tumour response following neoadjuvant therapy in T4 primary rectal cancer. Eur J Surg Oncol 2017; 43 (01) 92-99
    CrossrefPubMedGoogle Scholar
  • 25 Hashiguchi Y, Sekine T, Sakamoto H. , et al. Intraoperative irradiation after surgery for locally recurrent rectal cancer. Dis Colon Rectum 1999; 42 (07) 886-893 , discussion 893–895
    CrossrefPubMedGoogle Scholar
  • 26 Kusters M, Valentini V, Calvo FA. , et al. Results of European pooled analysis of IORT-containing multimodality treatment for locally advanced rectal cancer: adjuvant chemotherapy prevents local recurrence rather than distant metastases. Ann Oncol 2010; 21 (06) 1279-1284
    CrossrefPubMedGoogle Scholar
  • 27 Dubois JB, Bussieres E, Richaud P. , et al. Intra-operative radiotherapy of rectal cancer: results of the French multi-institutional randomized study. Radiother Oncol 2011; 98 (03) 298-303
    CrossrefPubMedGoogle Scholar
  • 28 van Stiphout RG, Lammering G, Buijsen J. , et al. Development and external validation of a predictive model for pathological complete response of rectal cancer patients including sequential PET-CT imaging. Radiother Oncol 2011; 98 (01) 126-133
    CrossrefPubMedGoogle Scholar
  • 29 Cammà C, Giunta M, Fiorica F, Pagliaro L, Craxì A, Cottone M. Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. JAMA 2000; 284 (08) 1008-1015
    CrossrefPubMedGoogle Scholar
  • 30 Genovesi D, Myerson RJ, Cèfaro GA. , et al; G.I. A.I.R.O. Working Group. Postoperative 5-FU based radiochemotherapy in rectal cancer: retrospective long term results and prognostic factors of a pooled analysis on 1,338 patients. Anticancer Res 2013; 33 (10) 4557-4566
    PubMedGoogle Scholar
  • 31 Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer 1948; 1 (02) 177-183
    CrossrefPubMedGoogle Scholar
  • 32 Dresen RC, Gosens MJ, Martijn H. , et al. Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol 2008; 15 (07) 1937-1947
    CrossrefPubMedGoogle Scholar
  • 33 Bouchard P, Efron J. Management of recurrent rectal cancer. Ann Surg Oncol 2010; 17 (05) 1343-1356
    CrossrefPubMedGoogle Scholar
  • 34 Pawlik TM, Skibber JM, Rodriguez-Bigas MA. Pelvic exenteration for advanced pelvic malignancies. Ann Surg Oncol 2006; 13 (05) 612-623
    CrossrefPubMedGoogle Scholar
  • 35 Suzuki K, Dozois RR, Devine RM. , et al. Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum 1996; 39 (07) 730-736
    CrossrefPubMedGoogle Scholar
  • 36 Yamada K, Ishizawa T, Niwa K, Chuman Y, Akiba S, Aikou T. Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer. Br J Surg 2001; 88 (07) 988-993
    CrossrefPubMedGoogle Scholar
  • 37 Mohiuddin M, Marks GM, Lingareddy V, Marks J. Curative surgical resection following reirradiation for recurrent rectal cancer. Int J Radiat Oncol Biol Phys 1997; 39 (03) 643-649
    CrossrefPubMedGoogle Scholar
  • 38 Wasserman K. Diagnosing cardiovascular and lung pathophysiology from exercise gas exchange. Chest 1997; 112 (04) 1091-1101
    CrossrefPubMedGoogle Scholar
  • 39 Belardinelli R, Lacalaprice F, Carle F. , et al. Exercise-induced myocardial ischaemia detected by cardiopulmonary exercise testing. Eur Heart J 2003; 24 (14) 1304-1313
    CrossrefPubMedGoogle Scholar
  • 40 Abbas SM, Hill AG. Systematic review of the literature for the use of oesophageal Doppler monitor for fluid replacement in major abdominal surgery. Anaesthesia 2008; 63 (01) 44-51
    PubMedGoogle Scholar
  • 41 Bhangu A, Ali SM, Brown G, Nicholls RJ, Tekkis P. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer. Ann Surg 2014; 259 (02) 315-322
    CrossrefPubMedGoogle Scholar
  • 42 Schneider A, Köhler C, Erdemoglu E. Current developments for pelvic exenteration in gynecologic oncology. Curr Opin Obstet Gynecol 2009; 21 (01) 4-9
    CrossrefPubMedGoogle Scholar
  • 43 Austin KK, Solomon MJ. Pelvic exenteration with en bloc iliac vessel resection for lateral pelvic wall involvement. Dis Colon Rectum 2009; 52 (07) 1223-1233
    CrossrefPubMedGoogle Scholar
  • 44 Zoucas E, Frederiksen S, Lydrup ML, Månsson W, Gustafson P, Alberius P. Pelvic exenteration for advanced and recurrent malignancy. World J Surg 2010; 34 (09) 2177-2184
    CrossrefPubMedGoogle Scholar
  • 45 Ramirez PT, Modesitt SC, Morris M. , et al. Functional outcomes and complications of continent urinary diversions in patients with gynecologic malignancies. Gynecol Oncol 2002; 85 (02) 285-291
    CrossrefPubMedGoogle Scholar
  • 46 Buchel EW, Finical S, Johnson C. Pelvic reconstruction using vertical rectus abdominis musculocutaneous flaps. Ann Plast Surg 2004; 52 (01) 22-26
    CrossrefPubMedGoogle Scholar
  • 47 Kakuda JT, Lamont JP, Chu DZ, Paz IB. The role of pelvic exenteration in the management of recurrent rectal cancer. Am J Surg 2003; 186 (06) 660-664
    CrossrefPubMedGoogle Scholar
  • 48 Saito N, Koda K, Takiguchi N. , et al. Curative surgery for local pelvic recurrence of rectal cancer. Dig Surg 2003; 20 (03) 192-199 , discussion 200
    CrossrefPubMedGoogle Scholar
  • 49 Nishio M, Sakakura C, Nagata T. , et al. Outcomes of total pelvic exenteration for colorectal cancer. Hepatogastroenterology 2009; 56 (96) 1637-1641
    PubMedGoogle Scholar
  • 50 Wells BJ, Stotland P, Ko MA. , et al. Results of an aggressive approach to resection of locally recurrent rectal cancer. Ann Surg Oncol 2007; 14 (02) 390-395
    CrossrefPubMedGoogle Scholar
  • 51 Boyle KM, Sagar PM, Chalmers AG, Sebag-Montefiore D, Cairns A, Eardley I. Surgery for locally recurrent rectal cancer. Dis Colon Rectum 2005; 48 (05) 929-937
    CrossrefPubMedGoogle Scholar
  • 52 Wanebo HJ, Antoniuk P, Koness RJ. , et al. Pelvic resection of recurrent rectal cancer: technical considerations and outcomes. Dis Colon Rectum 1999; 42 (11) 1438-1448
    CrossrefPubMedGoogle Scholar
  • 53 Ferenschild FT, Vermaas M, Verhoef C. , et al. Total pelvic exenteration for primary and recurrent malignancies. World J Surg 2009; 33 (07) 1502-1508
    CrossrefPubMedGoogle Scholar
  • 54 Houvenaeghel G, Moutardier V, Karsenty G. , et al. Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients. Gynecol Oncol 2004; 92 (02) 680-683
    CrossrefPubMedGoogle Scholar
  • 55 Jimenez RE, Shoup M, Cohen AM, Paty PB, Guillem J, Wong WD. Contemporary outcomes of total pelvic exenteration in the treatment of colorectal cancer. Dis Colon Rectum 2003; 46 (12) 1619-1625
    CrossrefPubMedGoogle Scholar
  • 56 Grossmann I, de Bock GH, Meershoek-Klein Kranenbarg WM, van de Velde CJ, Wiggers T. Carcinoembryonic antigen (CEA) measurement during follow-up for rectal carcinoma is useful even if normal levels exist before surgery. A retrospective study of CEA values in the TME trial. Eur J Surg Oncol 2007; 33 (02) 183-187
    CrossrefPubMedGoogle Scholar
  • 57 Young JM, Badgery-Parker T, Masya LM. , et al. Quality of life and other patient-reported outcomes following exenteration for pelvic malignancy. Br J Surg 2014; 101 (03) 277-287
    CrossrefPubMedGoogle Scholar
  • 58 Yang TX, Morris DL, Chua TC. Pelvic exenteration for rectal cancer: a systematic review. Dis Colon Rectum 2013; 56 (04) 519-531
    CrossrefPubMedGoogle Scholar
  • 59 Thaysen HV, Jess P, Laurberg S. Health-related quality of life after surgery for primary advanced rectal cancer and recurrent rectal cancer: a review. Colorectal Dis 2012; 14 (07) 797-803
    CrossrefPubMedGoogle Scholar
  • 60 You YN, Habiba H, Chang GJ, Rodriguez-bigas MA, Skibber JM. Prognostic value of quality of life and pain in patients with locally recurrent rectal cancer. Ann Surg Oncol 2011; 18 (04) 989-996
    CrossrefPubMedGoogle Scholar